Status
Conditions
Treatments
About
The investigators want to have a collection of fresh primary or recurrent tumor tissue for establishment of patients-derived xenografts in order to:
generate a biobank of in vivo patient xenografts representing the different subgroups of tumors for head and neck cancer
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Loading...
Central trial contact
Aline Gillain, MedSciences; Sandra Schmitz, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal